AUSTIN, Texas, March 29, 2021 (GLOBE NEWSWIRE) -- Escher Biomedical Diagnostics, LLC announced that its Escher BT-MED® COV19 Saliva Test has been accepted by FDA as a Notification under Section IV.C ...
HONG KONG, Mar 30, 2020 - (ACN Newswire) - - Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics for unmet needs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback